Ellington Financial INC
Market Movers (8-K)
NYSE
Ellington Financial Inc. announced an estimated book value per common share of $13.61 as of June 30, 2026.
NYSE
Ellington Financial Inc. announced a monthly common stock dividend of $0.13 per share, payable August 31, 2026.
NYSE
Ellington Financial Inc. announced an estimated book value per common share of $13.49 as of May 31, 2026.
NYSE
Ellington Financial Inc. announced monthly common stock dividends and quarterly preferred stock dividends for July 2026.
NYSE
Ellington Financial Inc. stockholders approved the 2026 Equity Incentive Plan and elected six directors at the annual meeting.
NYSE
Ellington Financial Inc. announced an estimated book value per common share of $13.43 as of April 30, 2026.
Quarterly Earnings (10-Q)
NYSE
Ellington Financial Inc. announced a significant increase in net income and EPS for the third quarter of 2025, driven by robust performance in its investment and Longbridge segments.
Capital raise
Better than expected
NYSE
Ellington Financial Inc. reported a decrease in GAAP net income for Q2 2025 but saw an increase in Adjusted Distributable Earnings and improved debt-to-equity ratios, driven by strong performance in its Longbridge segment and strategic portfolio adjustments.
Better than expected
Capital raise
NYSE
Ellington Financial Inc. reports its financial results for the first quarter of 2025, showcasing strategic asset management amidst market fluctuations.
NYSE
Ellington Financial Inc. reports a net income attributable to common stockholders of $16.2 million for the third quarter of 2024, compared to $6.6 million for the same period in 2023.
Better than expected
Capital raise
NYSE
Ellington Financial Inc. reports a complex second quarter with increased net income but also significant fluctuations in asset values and interest rate impacts.
Better than expected
NYSE
Ellington Financial Inc. reported its financial results for the first quarter of 2024, showing a net income attributable to common stockholders of $26.9 million.
Worse than expected
Capital raise
Annual Reports (10-K)
NYSE
Ellington Financial Inc. achieved significant portfolio growth and strong financial performance in 2025, driven by strategic investments and robust segment results.
Capital raise
Better than expected
NYSE
Ellington Financial Inc. reports its 2024 financial results, highlighting a strategic portfolio shift and increased capital base following the Arlington Asset Investment Corp. merger.
NYSE
Ellington Financial Inc.'s 10-K filing details the company's registered securities, including common stock and several series of preferred stock, all listed on the NYSE.
Insider Trading (Form 4)
NYSE
Co-Chief Investment Officer Michael W. Vranos reported the acquisition of 161,934 shares of Ellington Financial Inc. common stock as part of a quarterly incentive fee payment.
NYSE
Ellington Financial Inc. Director Lisa Mumford converted 7,657 OP LTIP Units into common stock, increasing her direct beneficial ownership to 88,773 shares.
NYSE
Ellington Financial's Chief Accounting Officer, Chris Smernoff, acquired 18,209 OP LTIP Units, vesting over two years, as part of the company's equity incentive plan.
NYSE
Ellington Financial Inc.'s Chief Financial Officer, John Herlihy, was granted 36,417 OP LTIP Units as part of the company's 2017 Equity Incentive Plan.
NYSE
Ellington Financial Inc. Director Edward Resendez acquired 9,198 OP LTIP Units, subject to vesting, aligning his interests with shareholders.
NYSE
Ellington Financial Inc. Director Ronald I. Simon acquired 9,198 shares as a grant and purchased an additional 5,544 shares, increasing his beneficial ownership.
Proxy Statements (Def-14A)
NYSE
Ellington Financial Inc. has filed a definitive proxy statement with the SEC, indicating upcoming shareholder meetings and voting on key company matters.
NYSE
Ellington Financial Inc. will hold its 2025 Annual Meeting of Stockholders virtually on May 29, 2025, to vote on director elections, executive compensation, and the ratification of the independent auditor.
NYSE
Ellington Financial Inc. has filed a definitive proxy statement with the SEC, signaling upcoming shareholder actions.
NYSE
Ellington Financial Inc. is holding its annual meeting on May 17, 2024, to vote on director elections, executive compensation, auditor ratification, and an amendment to increase authorized common shares.
Capital raise
Schedule 13G - Passive Investments
NYSE
Vanguard Capital Management has reported beneficial ownership of 5% of Ellington Financial Inc.'s common stock as of June 30, 2026.
NYSE
The Vanguard Group reported 0% beneficial ownership in Ellington Financial Inc. following an internal realignment for disaggregated reporting.
NYSE
SCHEDULE 13G/A: BlackRock Boosts Stake in Ellington Financial to 15.3%
BlackRock, Inc. has reported an increased beneficial ownership of 15.3% in Ellington Financial Inc.'s common stock as of December 31, 2025.